Innovent Biologics, Inc. (IVBXF)
11.30
+0.40
(+3.72%)
USD |
OTCM |
Feb 27, 16:00
Innovent Biologics Market Cap : 19.31B for Feb. 27, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| CSPC Pharmaceutical Group Ltd. | 14.19B |
| Sinovac Biotech Ltd. | 464.94M |
| CASI Pharmaceuticals, Inc. | 4.708M |
| Zai Lab Ltd. | 2.154B |
| WuXi Biologics (Cayman), Inc. | 20.75B |
Market Cap Related Metrics
| PS Ratio | 11.89 |
| Price to Free Cash Flow | 136.57 |
| Price | 11.30 |
| Earnings Yield | 0.83% |
| Operating PE Ratio | 77.23 |
| Normalized PE Ratio | 132.73 |